• CEPI to provide up to $388m for Novavax’s Covid-19 vaccine pharmaceutical-technology
    May 13, 2020
    The Coalition for Epidemic Preparedness Innovations (CEPI) has agreed to provide up to $384m in funding to support Novavax in the development and manufacturing of Covid-19 vaccine candidate, NVX-CoV2373.
PharmaSources Customer Service